NCT06164327 2023-12-11
Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
BeBetter Med Inc
Phase 1 Unknown
BeBetter Med Inc
Zhejiang University
Zhejiang University
Guangzhou Institute of Respiratory Disease
National Cancer Institute (NCI)
National Cancer Institute (NCI)